182 related articles for article (PubMed ID: 17017938)
1. Expression, distribution and regulation of phosphodiesterase 5.
Lin CS; Lin G; Xin ZC; Lue TF
Curr Pharm Des; 2006; 12(27):3439-57. PubMed ID: 17017938
[TBL] [Abstract][Full Text] [Related]
2. Tissue expression, distribution, and regulation of PDE5.
Lin CS
Int J Impot Res; 2004 Jun; 16 Suppl 1():S8-S10. PubMed ID: 15224128
[TBL] [Abstract][Full Text] [Related]
3. Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters.
Lin CS; Chow S; Lau A; Tu R; Lue TF
Int J Impot Res; 2002 Feb; 14(1):15-24. PubMed ID: 11896473
[TBL] [Abstract][Full Text] [Related]
4. Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum.
Lin CS; Lau A; Tu R; Lue TF
Biochem Biophys Res Commun; 2000 Feb; 268(2):628-35. PubMed ID: 10679255
[TBL] [Abstract][Full Text] [Related]
5. Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiesterases.
Kotera J; Fujishige K; Imai Y; Kawai E; Michibata H; Akatsuka H; Yanaka N; Omori K
Eur J Biochem; 1999 Jun; 262(3):866-73. PubMed ID: 10411650
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human PDE5A2 intronic promoter by cAMP and cGMP: identification of a critical Sp1-binding site.
Lin CS; Chow S; Lau A; Tu R; Lue TF
Biochem Biophys Res Commun; 2001 Jan; 280(3):693-9. PubMed ID: 11162576
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
Murray F; MacLean MR; Pyne NJ
Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
[TBL] [Abstract][Full Text] [Related]
8. Identification and regulation of human PDE5A gene promoter.
Lin CS; Chow S; Lau A; Tu R; Lue TF
Biochem Biophys Res Commun; 2001 Jan; 280(3):684-92. PubMed ID: 11162575
[TBL] [Abstract][Full Text] [Related]
9. Isolation of two isoforms of phosphodiesterase 5 from rat penis.
Lin CS; Lin G; Lue TF
Int J Impot Res; 2003 Apr; 15(2):129-36. PubMed ID: 12789393
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase.
Loughney K; Hill TR; Florio VA; Uher L; Rosman GJ; Wolda SL; Jones BA; Howard ML; McAllister-Lucas LM; Sonnenburg WK; Francis SH; Corbin JD; Beavo JA; Ferguson K
Gene; 1998 Aug; 216(1):139-47. PubMed ID: 9714779
[TBL] [Abstract][Full Text] [Related]
11. Hydropathic analysis and mutagenesis of the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). cGMP versus cAMP substrate selectivity.
Turko IV; Francis SH; Corbin JD
Biochemistry; 1998 Mar; 37(12):4200-5. PubMed ID: 9521742
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds.
Turko IV; Ballard SA; Francis SH; Corbin JD
Mol Pharmacol; 1999 Jul; 56(1):124-30. PubMed ID: 10385692
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells.
Rybalkin SD; Rybalkina IG; Feil R; Hofmann F; Beavo JA
J Biol Chem; 2002 Feb; 277(5):3310-7. PubMed ID: 11723116
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities.
Corbin JD; Turko IV; Beasley A; Francis SH
Eur J Biochem; 2000 May; 267(9):2760-7. PubMed ID: 10785399
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.
Nagendran J; Archer SL; Soliman D; Gurtu V; Moudgil R; Haromy A; St Aubin C; Webster L; Rebeyka IM; Ross DB; Light PE; Dyck JR; Michelakis ED
Circulation; 2007 Jul; 116(3):238-48. PubMed ID: 17606845
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling.
Kim D; Aizawa T; Wei H; Pi X; Rybalkin SD; Berk BC; Yan C
J Mol Cell Cardiol; 2005 Jan; 38(1):175-84. PubMed ID: 15623434
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of sildenafil in hypertensive men with erectile dysfunction and different alleles of the type 5 cGMP-specific phosphodiesterase (PDE5).
Salvi F; Sarzani R; Giorgi R; Donatelli G; Pietrucci F; Micheli A; Baldoni M; Minardi D; Dessì-Fulgheri P; Polito M; Muzzonigro G; Rappelli A
Int J Impot Res; 2004 Oct; 16(5):412-7. PubMed ID: 15175637
[TBL] [Abstract][Full Text] [Related]
18. PDE5 is converted to an activated state upon cGMP binding to the GAF A domain.
Rybalkin SD; Rybalkina IG; Shimizu-Albergine M; Tang XB; Beavo JA
EMBO J; 2003 Feb; 22(3):469-78. PubMed ID: 12554648
[TBL] [Abstract][Full Text] [Related]
19. The gamma subunit of the rod photoreceptor cGMP phosphodiesterase can modulate the proteolysis of two cGMP binding cGMP-specific phosphodiesterases (PDE6 and PDE5) by caspase-3.
Frame M; Wan KF; Tate R; Vandenabeele P; Pyne NJ
Cell Signal; 2001 Oct; 13(10):735-41. PubMed ID: 11602184
[TBL] [Abstract][Full Text] [Related]
20. The novel functions of cGMP-specific phosphodiesterase 5 and its inhibitors in carcinoma cells and pulmonary/cardiovascular vessels.
Zhu B; Strada SJ
Curr Top Med Chem; 2007; 7(4):437-54. PubMed ID: 17305584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
